This transition is typically marked by a gain of function in androgen receptor (AR) signaling [4], although the transcriptional read-out of such gain may be different from that elicited by AR signaling in hormone-sensitive prostate cancer cells (Wang et al., 2009). The gene discussed is AR; the disease is Familial prostate cancer.